218 related articles for article (PubMed ID: 17553133)
1. Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.
Conway K; Parrish E; Edmiston SN; Tolbert D; Tse CK; Moorman P; Newman B; Millikan RC
Breast Cancer Res; 2007; 9(3):R36. PubMed ID: 17553133
[TBL] [Abstract][Full Text] [Related]
2. The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.
Conway K; Parrish E; Edmiston SN; Tolbert D; Tse CK; Geradts J; Livasy CA; Singh H; Newman B; Millikan RC
Breast Cancer Res; 2005; 7(6):R871-80. PubMed ID: 16280033
[TBL] [Abstract][Full Text] [Related]
3. Association of estrogen receptor-α A908G (K303R) mutation with breast cancer risk.
Abbasi S; Rasouli M; Nouri M; Kalbasi S
Int J Clin Exp Med; 2013; 6(1):39-49. PubMed ID: 23236557
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast.
Tebbit CL; Bentley RC; Olson JA; Marks JR
Genes Chromosomes Cancer; 2004 May; 40(1):51-4. PubMed ID: 15034868
[TBL] [Abstract][Full Text] [Related]
5. Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.
Herynk MH; Parra I; Cui Y; Beyer A; Wu MF; Hilsenbeck SG; Fuqua SA
Clin Cancer Res; 2007 Jun; 13(11):3235-43. PubMed ID: 17545528
[TBL] [Abstract][Full Text] [Related]
6. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.
Brinton LA; Gammon MD; Malone KE; Schoenberg JB; Daling JR; Coates RJ
Contraception; 1997 Apr; 55(4):197-203. PubMed ID: 9179450
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
8. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.
Mayberry RM
Ann Epidemiol; 1994 May; 4(3):205-13. PubMed ID: 8055121
[TBL] [Abstract][Full Text] [Related]
9. Use of oral contraceptives and risk of breast cancer in young women.
Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L
Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and breast cancer: a cooperative Italian study.
La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
14. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.
Zheng Y; Huo D; Zhang J; Yoshimatsu TF; Niu Q; Olopade OI
PLoS One; 2012; 7(7):e40494. PubMed ID: 22792352
[TBL] [Abstract][Full Text] [Related]
15. Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women.
Sweeney C; Giuliano AR; Baumgartner KB; Byers T; Herrick JS; Edwards SL; Slattery ML
Int J Cancer; 2007 Dec; 121(11):2517-23. PubMed ID: 17657739
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.
Figueiredo JC; Haile RW; Bernstein L; Malone KE; Largent J; Langholz B; Lynch CF; Bertelsen L; Capanu M; Concannon P; Borg A; Børresen-Dale AL; Diep A; Teraoka S; Torngren T; Xue S; Bernstein JL
Breast Cancer Res Treat; 2010 Feb; 120(1):175-83. PubMed ID: 19597986
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive agents and breast cancer: a population-based case-control study.
Rohan TE; McMichael AJ
Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
Rosenberg L; Bethea TN; Viscidi E; Hong CC; Troester MA; Bandera EV; Haiman CA; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613937
[TBL] [Abstract][Full Text] [Related]
19. The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials.
Najim O; Seghers S; Sergoynne L; Van Gaver H; Papadimitriou K; Wouters K; Trinh XB; Huizing MT; Tjalma W
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188315. PubMed ID: 31647985
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
